(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

4LIFE TRANSFER FACTOR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

4LIFE TRANSFER FACTOR

ST13

US500000078344235

Class

5

Filing

78344235

Registration

2927894

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

05/09/2025

Trademark type

Word

Nice classes

5

Filing date

12/22/2003

Registration date

02/22/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/01/2024

Last transaction

05/09/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

01/01/1998

First use in commerce

01/01/1998

Drawing code

4

Owner type

16

Owner location

SANDY, UT

Examiner

RINGLE, JIM

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

4LIFE TRADEMARKS, LLC
4Life Research LC

Representatives

Glenn S. Bacal BACAL LAW GROUP PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary and nutritional supplements; vitaminmineral and herbal supplements; immune factor preparations intended to enhance and stimulate the immune system

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/01/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

06/01/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/01/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/01/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

02/23/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/22/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/11/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/11/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/11/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/10/2014

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

03/27/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

03/27/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/12/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/12/2010

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/03/2010

E815

TEAS SECTION 8 & 15 RECEIVED

02/25/2010

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/14/2010

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/23/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/15/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/12/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/12/2007

CORV

REVIEW OF CORRESPONDENCE COMPLETE

06/15/2006

MAIL

PAPER RECEIVED

07/08/2005

R.PR

REGISTERED-PRINCIPAL REGISTER

02/22/2005

PUBO

PUBLISHED FOR OPPOSITION

11/30/2004

NPUB

NOTICE OF PUBLICATION

11/10/2004

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/30/2004

ALIE

ASSIGNED TO LIE

09/30/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/18/2004

ACEC

AMENDMENT FROM APPLICANT ENTERED

09/16/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2004

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/09/2004

GNRT

NON-FINAL ACTION E-MAILED

07/13/2004

DOCK

ASSIGNED TO EXAMINER

07/13/2004

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/23/2004

NWAP

NEW APPLICATION ENTERED

01/07/2004

Continuous trademark protection

Get notified about every new filing that threatens 4LIFE TRANSFER FACTOR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.